Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts

被引:63
|
作者
Yang, Zhishi [1 ,2 ]
Qin, Wenhao [1 ,3 ]
Chen, Yao [1 ,3 ]
Yuan, Bo [1 ,3 ]
Song, Xiaoling [1 ,3 ]
Wang, Bibo [1 ,3 ]
Shen, Feng [1 ,2 ]
Fu, Jing [1 ,3 ,4 ]
Wang, Hongyang [1 ,3 ]
机构
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China
[2] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai 200438, Peoples R China
[3] Natl Ctr Liver Canc, Shanghai, Peoples R China
[4] Fujian Med Univ, Mengchao Hepatobiliary Hosp, Fuzhou, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
Cholesterol; HCC; Metastasis; CD44; Lipid raft; PREOPERATIVE SERUM-CHOLESTEROL; BREAST-CANCER; CELLS; ACCUMULATION; CYTOSKELETON; LEVEL;
D O I
10.1016/j.canlet.2018.04.038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cholesterol plays a vital role in modulating the action of membrane proteins critical to cellular function. The effect of serum cholesterol on the prognosis of hepatocellular carcinoma (HCC) patients remains uncertain. Here, we report that high levels of cholesterol predict good survival and low disease recurrence after surgery. Cholesterol could significantly suppress migration and invasion of HCC cells and restrain metastasis of HCC in mice. High levels of cholesterol promoted CD44 translocation into lipid rafts and attenuated CD44-Ezrin binding, which are crucial for cell migration and cancer metastasis. The suppressive effect of cholesterol on HCC metastasis was abolished by the downregulation of CD44 or its palmitoylation inhibitor, which blocked CD44 localization in lipid rafts. Furthermore, pharmacologically promoting CD44 retention inside lipid rafts obviously attenuated HCC migration and invasion, providing a potential therapeutic strategy to prolong the survival of HCC patients. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:66 / 77
页数:12
相关论文
共 50 条
  • [21] shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells
    Park, Yeon Sun
    Huh, Jung Wook
    Lee, Jae Hyuk
    Kim, Hyeong Rok
    ONCOLOGY REPORTS, 2012, 27 (02) : 339 - 346
  • [22] CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
    Zhang, Jun
    He, Xilin
    Wan, Yajie
    Zhang, Honghong
    Tang, Tao
    Zhang, Meng
    Yu, Shiyi
    Zhao, Weiyong
    Chen, Liming
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [23] CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
    Chou, Ying-Erh
    Hsieh, Ming-Ju
    Chiou, Hui-Ling
    Lee, Hsiang-Lin
    Yang, Shun-Fa
    Chen, Tzy-Yen
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [24] CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
    Jun Zhang
    Xilin He
    Yajie Wan
    Honghong Zhang
    Tao Tang
    Meng Zhang
    Shiyi Yu
    Weiyong Zhao
    Liming Chen
    Experimental Hematology & Oncology, 10
  • [25] CD44 engagement promotes matrix-derived survival through the CD44-Src-integrin axis in lipid rafts
    Lee, Jia-Lin
    Wang, Mei-Jung
    Sudhir, Putty-Reddy
    Chen, Jeou-Yuan
    MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (18) : 5710 - 5723
  • [26] Myosin 1g Contributes to CD44 Adhesion Protein and Lipid Rafts Recycling and Controls CD44 Capping and Cell Migration in B Lymphocytes
    Lopez-Ortega, Orestes
    Santos-Argumedo, Leopoldo
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [27] Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44
    Wang, Weiyi
    Zhang, Mengzhao
    Huang, Zhixin
    Wang, Lu
    Yue, Yangyang
    Wang, Xinyang
    Lu, Shaoying
    Fan, Jinhai
    ANTI-CANCER DRUGS, 2022, 33 (01) : E103 - E112
  • [28] miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines
    Henry, Jon C.
    Park, Jong-Kook
    Jiang, Jinmai
    Kim, Ji Hye
    Nagorney, David M.
    Roberts, Lewis R.
    Banerjee, Soma
    Schmittgen, Thomas D.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 403 (01) : 120 - 125
  • [29] miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines
    Henry, Jon C.
    Park, Jong-Kook
    Jiang, Jinmai
    Kim, Ji Hye
    Roberts, Lewis R.
    Nagorney, David M.
    Banerjee, Soma
    Schmittgen, Thomas D.
    CANCER RESEARCH, 2011, 71
  • [30] The standard form of CD44 as a marker for invasion of encapsulated papillary carcinoma of the breast
    Kato, Hiroyuki
    Naiki-Ito, Aya
    Yamada, Takehiro
    Suzuki, Shugo
    Yamashita, Yoriko
    Inaguma, Shingo
    Kondo, Naoto
    Wanifuchi-Endo, Yumi
    Toyama, Tatsuya
    Takahashi, Satoru
    PATHOLOGY INTERNATIONAL, 2020, 70 (11) : 835 - 843